ALEXIS MCAFEE: Open Payments
NPI 1538812318 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,567 in 77 payments from 22 companies in 2025. Trend: 2023 $2,316 · 2024 $1,910 · 2025 $1,567
Food & beverage: $1,567
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $334 |
| Corcept Therapeutics | 15 | $323 |
| Vanda Pharmaceuticals Inc. | 10 | $159 |
| AstraZeneca Pharmaceuticals LP | 6 | $148 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Lilly USA, LLC | 2 | $51 |
| PFIZER INC. | 2 | $48 |
| Lundbeck LLC | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $41 |
Products named: CAPLYTA, Korlym, FANAPT, FARXIGA, TRELEGY ELLIPTA, Kerendia, AIRSUPRA, JARDIANCE.
Industry payments across FL — which companies pay providers there.
